Encision Inc. (ECIA)
USD 0.35
(0.0%)
USD 0.35
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 3.77 Million USD | -12.9% |
| 2023 | 4.33 Million USD | -1.07% |
| 2022 | 4.38 Million USD | 10.51% |
| 2021 | 3.96 Million USD | -4.66% |
| 2020 | 4.16 Million USD | -14.37% |
| 2019 | 4.85 Million USD | 5.36% |
| 2018 | 4.61 Million USD | -9.48% |
| 2017 | 5.09 Million USD | -3.61% |
| 2016 | 5.28 Million USD | -10.1% |
| 2015 | 5.87 Million USD | -0.21% |
| 2014 | 5.89 Million USD | -16.84% |
| 2013 | 7.08 Million USD | -5.5% |
| 2012 | 7.49 Million USD | 4.66% |
| 2011 | 7.16 Million USD | -5.26% |
| 2010 | 7.56 Million USD | -2.56% |
| 2009 | 7.75 Million USD | 0.03% |
| 2008 | 7.75 Million USD | 10.25% |
| 2007 | 7.03 Million USD | 18.99% |
| 2006 | 5.91 Million USD | 12.16% |
| 2005 | 5.27 Million USD | 23.4% |
| 2004 | 4.27 Million USD | 11.47% |
| 2003 | 3.83 Million USD | 28.23% |
| 2002 | 2.98 Million USD | 5.05% |
| 2001 | 2.84 Million USD | 1.47% |
| 2000 | 2.8 Million USD | -3.61% |
| 1999 | 2.9 Million USD | -21.12% |
| 1998 | 3.68 Million USD | 6.05% |
| 1997 | 3.47 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 991 Thousand USD | -9.74% |
| 2024 Q3 | 916.63 Thousand USD | 7.08% |
| 2024 FY | 3.77 Million USD | -12.9% |
| 2024 Q4 | 1.04 Million USD | 14.33% |
| 2024 Q2 | 856 Thousand USD | -13.62% |
| 2023 Q3 | 1.1 Million USD | -0.13% |
| 2023 FY | 4.33 Million USD | -1.07% |
| 2023 Q4 | 1.09 Million USD | -0.99% |
| 2023 Q2 | 1.11 Million USD | 9.19% |
| 2023 Q1 | 1.01 Million USD | -16.02% |
| 2022 Q1 | 1.03 Million USD | 1.88% |
| 2022 FY | 4.38 Million USD | 10.51% |
| 2022 Q4 | 1.21 Million USD | 18.03% |
| 2022 Q3 | 1.02 Million USD | -7.98% |
| 2022 Q2 | 1.11 Million USD | 8.04% |
| 2021 Q1 | 796 Thousand USD | -23.24% |
| 2021 FY | 3.96 Million USD | -4.66% |
| 2021 Q2 | 1.06 Million USD | 33.92% |
| 2021 Q4 | 1.01 Million USD | -7.32% |
| 2021 Q3 | 1.09 Million USD | 2.53% |
| 2020 FY | 4.16 Million USD | -14.37% |
| 2020 Q4 | 1.03 Million USD | 4.01% |
| 2020 Q3 | 997 Thousand USD | -1.68% |
| 2020 Q1 | 1.11 Million USD | -13.39% |
| 2020 Q2 | 1.01 Million USD | -8.81% |
| 2019 Q2 | 1.16 Million USD | -7.76% |
| 2019 FY | 4.85 Million USD | 5.36% |
| 2019 Q4 | 1.28 Million USD | 12.03% |
| 2019 Q3 | 1.14 Million USD | -1.63% |
| 2019 Q1 | 1.26 Million USD | 7.67% |
| 2018 FY | 4.61 Million USD | -9.48% |
| 2018 Q3 | 1.16 Million USD | 2.92% |
| 2018 Q4 | 1.17 Million USD | 0.86% |
| 2018 Q2 | 1.13 Million USD | -1.4% |
| 2018 Q1 | 1.14 Million USD | -7.73% |
| 2017 Q2 | 1.25 Million USD | -1.73% |
| 2017 Q4 | 1.24 Million USD | -6.05% |
| 2017 FY | 5.09 Million USD | -3.61% |
| 2017 Q1 | 1.27 Million USD | -3.12% |
| 2017 Q3 | 1.32 Million USD | 5.51% |
| 2016 Q2 | 1.3 Million USD | -3.34% |
| 2016 FY | 5.28 Million USD | -10.1% |
| 2016 Q4 | 1.31 Million USD | -0.3% |
| 2016 Q3 | 1.32 Million USD | 1.38% |
| 2016 Q1 | 1.34 Million USD | -9.78% |
| 2015 Q4 | 1.49 Million USD | -5.45% |
| 2015 FY | 5.87 Million USD | -0.21% |
| 2015 Q1 | 1.36 Million USD | -8.15% |
| 2015 Q2 | 1.43 Million USD | 5.19% |
| 2015 Q3 | 1.57 Million USD | 9.73% |
| 2014 Q1 | 1.69 Million USD | -1.86% |
| 2014 Q3 | 1.32 Million USD | -4.19% |
| 2014 Q2 | 1.38 Million USD | -18.2% |
| 2014 FY | 5.89 Million USD | -16.84% |
| 2014 Q4 | 1.48 Million USD | 12.32% |
| 2013 Q3 | 1.74 Million USD | -6.72% |
| 2013 Q1 | 1.73 Million USD | -8.07% |
| 2013 Q2 | 1.87 Million USD | 7.94% |
| 2013 FY | 7.08 Million USD | -5.5% |
| 2013 Q4 | 1.72 Million USD | -1.43% |
| 2012 Q1 | 1.78 Million USD | 7.08% |
| 2012 Q4 | 1.88 Million USD | 4.78% |
| 2012 Q2 | 2.01 Million USD | 12.93% |
| 2012 Q3 | 1.8 Million USD | -10.64% |
| 2012 FY | 7.49 Million USD | 4.66% |
| 2011 Q4 | 1.66 Million USD | 6.05% |
| 2011 Q1 | 1.95 Million USD | -1.12% |
| 2011 FY | 7.16 Million USD | -5.26% |
| 2011 Q3 | 1.57 Million USD | -20.01% |
| 2011 Q2 | 1.96 Million USD | 0.69% |
| 2010 FY | 7.56 Million USD | -2.56% |
| 2010 Q1 | 1.85 Million USD | -4.28% |
| 2010 Q2 | 1.88 Million USD | 1.59% |
| 2010 Q3 | 1.84 Million USD | -1.85% |
| 2010 Q4 | 1.97 Million USD | 6.9% |
| 2009 Q2 | 1.96 Million USD | -3.42% |
| 2009 Q4 | 1.93 Million USD | 5.68% |
| 2009 Q1 | 2.02 Million USD | 3.58% |
| 2009 FY | 7.75 Million USD | 0.03% |
| 2009 Q3 | 1.83 Million USD | -6.52% |
| 2008 Q1 | 1.91 Million USD | -1.56% |
| 2008 Q4 | 1.95 Million USD | -0.05% |
| 2008 Q3 | 1.96 Million USD | 2.1% |
| 2008 Q2 | 1.92 Million USD | 0.19% |
| 2008 FY | 7.75 Million USD | 10.25% |
| 2007 Q3 | 1.79 Million USD | 6.34% |
| 2007 Q2 | 1.68 Million USD | 4.85% |
| 2007 FY | 7.03 Million USD | 18.99% |
| 2007 Q4 | 1.94 Million USD | 8.53% |
| 2007 Q1 | 1.6 Million USD | 1.77% |
| 2006 Q1 | 1.37 Million USD | -1.07% |
| 2006 Q4 | 1.58 Million USD | 10.97% |
| 2006 Q3 | 1.42 Million USD | -7.34% |
| 2006 Q2 | 1.53 Million USD | 12.21% |
| 2006 FY | 5.91 Million USD | 12.16% |
| 2005 Q1 | 1.3 Million USD | 8.06% |
| 2005 Q3 | 1.32 Million USD | 5.95% |
| 2005 Q2 | 1.25 Million USD | -4.17% |
| 2005 FY | 5.27 Million USD | 23.4% |
| 2005 Q4 | 1.38 Million USD | 4.37% |
| 2004 Q4 | 1.2 Million USD | 14.42% |
| 2004 FY | 4.27 Million USD | 11.47% |
| 2004 Q3 | 1.05 Million USD | -1.38% |
| 2004 Q2 | 1.07 Million USD | 14.86% |
| 2004 Q1 | 933.27 Thousand USD | -9.02% |
| 2003 Q3 | 910.1 Thousand USD | -6.98% |
| 2003 Q2 | 978.45 Thousand USD | 6.57% |
| 2003 FY | 3.83 Million USD | 28.23% |
| 2003 Q1 | 918.11 Thousand USD | 1.93% |
| 2003 Q4 | 1.02 Million USD | 12.72% |
| 2002 Q2 | 708.45 Thousand USD | 12.57% |
| 2002 Q1 | 629.31 Thousand USD | -24.24% |
| 2002 Q3 | 750.18 Thousand USD | 5.89% |
| 2002 Q4 | 900.73 Thousand USD | 20.07% |
| 2002 FY | 2.98 Million USD | 5.05% |
| 2001 FY | 2.84 Million USD | 1.47% |
| 2001 Q4 | 830.71 Thousand USD | 10.86% |
| 2001 Q3 | 749.33 Thousand USD | 18.59% |
| 2001 Q2 | 631.88 Thousand USD | 1.14% |
| 2001 Q1 | 624.74 Thousand USD | -22.33% |
| 2000 Q3 | 744.59 Thousand USD | 0.0% |
| 2000 Q4 | 804.33 Thousand USD | 8.02% |
| 2000 FY | 2.8 Million USD | -3.61% |
| 1999 FY | 2.9 Million USD | -21.12% |
| 1998 FY | 3.68 Million USD | 6.05% |
| 1997 FY | 3.47 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -31.901% |
| Ansell Limited | 495.5 Million USD | 99.238% |
| Ansell Limited | 495.5 Million USD | 99.238% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | 95.439% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -118.214% |
| Psykey, Inc. | 1.21 Million USD | -211.233% |
| ConvaTec Group Plc | 910.31 Million USD | 99.585% |
| ConvaTec Group Plc | 872.5 Million USD | 99.567% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -2563.224% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -3335.56% |
| Innovative MedTech Inc. | 6.09 Million USD | 38.076% |
| LifePoint, Inc. | 7.42 Million USD | 49.127% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | 40.514% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -341.725% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -420.117% |
| Reflect Scientific, Inc. | 1.06 Million USD | -255.058% |
| SmileDirectClub, Inc. | 517 Million USD | 99.269% |
| Sector 10, Inc. | 39.84 Thousand USD | -9378.83% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 99.943% |
| SheerVision, Inc. | 2.33 Million USD | -61.978% |
| United Health Products, Inc. | 2.42 Million USD | -55.643% |
| Vasamed, Inc. | 4.67 Million USD | 19.178% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -47.425% |
| Yubo International Biotech Limited | 1.25 Million USD | -200.248% |